A detailed history of Cadinha & CO LLC transactions in Amgen Inc stock. As of the latest transaction made, Cadinha & CO LLC holds 5,209 shares of AMGN stock, worth $1.38 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
5,209
Previous 5,177 0.62%
Holding current value
$1.38 Million
Previous $1.62 Million 3.77%
% of portfolio
0.29%
Previous 0.3%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$309.38 - $337.38 $9,900 - $10,796
32 Added 0.62%
5,209 $1.68 Million
Q2 2024

Jul 30, 2024

BUY
$262.75 - $319.31 $43,879 - $53,324
167 Added 3.33%
5,177 $1.62 Million
Q4 2023

Jan 24, 2024

SELL
$255.7 - $288.46 $223,737 - $252,402
-875 Reduced 14.87%
5,010 $1.44 Million
Q3 2023

Nov 01, 2023

BUY
$218.65 - $271.46 $212,090 - $263,316
970 Added 19.74%
5,885 $1.58 Million
Q2 2023

Jul 26, 2023

SELL
$214.27 - $253.37 $5.71 Million - $6.76 Million
-26,663 Reduced 84.44%
4,915 $1.09 Million
Q1 2023

Apr 28, 2023

SELL
$225.79 - $275.2 $6.33 Million - $7.71 Million
-28,028 Reduced 47.02%
31,578 $7.63 Million
Q4 2022

Jan 25, 2023

BUY
$229.03 - $291.01 $12 Million - $15.3 Million
52,526 Added 741.89%
59,606 $0
Q2 2022

Aug 05, 2022

SELL
$230.71 - $256.74 $258,395 - $287,548
-1,120 Reduced 13.66%
7,080 $1.72 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $260,931 - $288,658
-1,190 Reduced 12.67%
8,200 $1.98 Million
Q4 2021

Feb 03, 2022

SELL
$198.88 - $227.6 $14.4 Million - $16.5 Million
-72,315 Reduced 88.51%
9,390 $2.11 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $224,793 - $263,373
1,059 Added 1.31%
81,705 $17.4 Million
Q2 2021

Jul 29, 2021

BUY
$233.58 - $259.14 $265,814 - $294,901
1,138 Added 1.43%
80,646 $19.7 Million
Q1 2021

May 06, 2021

SELL
$221.91 - $258.6 $1.32 Million - $1.54 Million
-5,965 Reduced 6.98%
79,508 $19.8 Million
Q4 2020

Jan 22, 2021

BUY
$216.38 - $257.67 $394,027 - $469,217
1,821 Added 2.18%
85,473 $19.7 Million
Q3 2020

Oct 30, 2020

BUY
$234.65 - $260.95 $338,599 - $376,550
1,443 Added 1.76%
83,652 $21.3 Million
Q2 2020

Jul 22, 2020

BUY
$197.81 - $242.74 $481,469 - $590,829
2,434 Added 3.05%
82,209 $19.4 Million
Q1 2020

May 06, 2020

BUY
$182.24 - $241.7 $13.3 Million - $17.6 Million
72,714 Added 1029.8%
79,775 $16.2 Million
Q4 2019

Jan 23, 2020

BUY
$189.21 - $243.2 $12,298 - $15,808
65 Added 0.93%
7,061 $1.7 Million
Q3 2019

Oct 30, 2019

SELL
$174.11 - $208.62 $42,482 - $50,903
-244 Reduced 3.37%
6,996 $1.35 Million
Q2 2019

Aug 09, 2019

SELL
$166.7 - $195.41 $11.7 Million - $13.8 Million
-70,408 Reduced 90.68%
7,240 $1.33 Million
Q1 2019

May 08, 2019

BUY
$180.87 - $203.88 $328,640 - $370,449
1,817 Added 2.4%
77,648 $14.8 Million
Q4 2018

Jan 29, 2019

BUY
$178.4 - $208.25 $9.52 Million - $11.1 Million
53,345 Added 237.24%
75,831 $14.8 Million
Q3 2018

Nov 07, 2018

BUY
$185.29 - $208.89 $3,705 - $4,177
20 Added 0.09%
22,486 $4.66 Million
Q2 2018

Aug 07, 2018

BUY
$166.05 - $186.51 $1.19 Million - $1.34 Million
7,175 Added 46.92%
22,466 $4.15 Million
Q1 2018

May 10, 2018

SELL
$169.43 - $198.0 $5.05 Million - $5.91 Million
-29,829 Reduced 66.11%
15,291 $2.61 Million
Q4 2017

Jan 29, 2018

BUY
$168.79 - $188.59 $5.46 Million - $6.1 Million
32,334 Added 252.89%
45,120 $7.85 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $2.14 Million - $2.44 Million
12,786
12,786 $2.38 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cadinha & CO LLC Portfolio

Follow Cadinha & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadinha & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cadinha & CO LLC with notifications on news.